Johnson & Johnson vs TotalEnergies SE: Strategic Comparison
Key Differences at a Glance
| Field | Johnson & Johnson | TotalEnergies SE |
|---|---|---|
| Revenue | $94.2B | $182.3B |
| Founded | 1886 | 1924 |
| Employees | 140,800 | 101,513 |
| Market Cap | $612.8B | $165.0B |
| Headquarters | United States | France |
Quick Stats Comparison
| Metric | Johnson & Johnson | TotalEnergies SE |
|---|---|---|
| Revenue | $94.2B | $182.3B |
| Founded | 1886 | 1924 |
| Headquarters | New Brunswick, New Jersey | Paris, France |
| Market Cap | $612.8B | $165.0B |
| Employees | 140,800 | 101,513 |
Johnson & Johnson Revenue vs TotalEnergies SE Revenue — Year by Year
| Year | Johnson & Johnson | TotalEnergies SE | Leader |
|---|---|---|---|
| 2025 | $94.2B | $182.3B | TotalEnergies SE |
| 2024 | $88.8B | $195.6B | TotalEnergies SE |
| 2023 | $85.2B | $218.9B | TotalEnergies SE |
Business Model Breakdown
Overview: Johnson & Johnson vs TotalEnergies SE
This in-depth comparison examines Johnson & Johnson and TotalEnergies SE across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Johnson & Johnson on its own, evaluating TotalEnergies SE, or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Johnson & Johnson and TotalEnergies SE is widest.
On the headline numbers, Johnson & Johnson reports annual revenue of $94.2B against $182.3B for TotalEnergies SE, while their respective market capitalizations stand at $612.8B and $165.0B. Johnson & Johnson is headquartered in United States and TotalEnergies SE operates from France, and those different home markets shape how each company competes.
Johnson & Johnson: Johnson & Johnson began as a medical-products company in the nineteenth century and became a diversified healthcare giant. After the Kenvue separation, it is a more focused healthcare company centered on medicine and medical technology.
TotalEnergies SE: TotalEnergies reported $182.344 billion in 2025 revenues from sales and $13.127 billion in net income attributable to TotalEnergies. The company remains a multi-energy major: oil and gas production, LNG, refining, marketing, electricity, and renewables all sit inside one capital-allocation system led by CEO Patrick Pouyanne.
Business Models: How Johnson & Johnson and TotalEnergies SE Make Money
Johnson & Johnson and TotalEnergies SE pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Johnson & Johnson and TotalEnergies SE.
Johnson & Johnson business model: Johnson & Johnson makes money by discovering, developing, manufacturing, and selling prescription medicines and medical technologies. Innovative Medicine sells therapies in oncology, immunology, neuroscience, pulmonary hypertension, infectious disease, and cardiovascular/metabolism. MedTech sells surgery, orthopaedics, cardiovascular, and vision products to hospitals, physicians, and healthcare systems.
TotalEnergies SE business model: TotalEnergies makes money from an integrated energy chain: exploration and production, LNG, refining and chemicals, marketing and services, electricity generation, power trading, renewable assets, and customer energy services.
Competitive Advantage: Johnson & Johnson vs TotalEnergies SE
The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Johnson & Johnson stack up against those of TotalEnergies SE.
Johnson & Johnson competitive advantage: Johnson & Johnson's advantage comes from scale, R&D depth, global regulatory capability, major oncology and immunology franchises, MedTech breadth, and a large commercial infrastructure.
TotalEnergies SE competitive advantage: TotalEnergies has an integrated LNG platform, upstream assets across multiple basins, downstream and marketing positions, and a growing power portfolio. Its advantage is breadth across molecules, refined products, and electrons.
Growth Strategy: Where Johnson & Johnson and TotalEnergies SE Are Headed
Future prospects matter as much as current results. The growth strategies below explain how Johnson & Johnson and TotalEnergies SE each plan to expand from here.
Johnson & Johnson growth strategy: The company is investing in oncology, immunology, neuroscience, cardiovascular MedTech, electrophysiology, surgery, R&D, acquisitions, and global commercial execution.
TotalEnergies SE growth strategy: TotalEnergies' strategy centers on low-cost oil and gas production, LNG integration, disciplined downstream operations, renewable power capacity, electricity customers, and cash returns to shareholders.
Financial Picture: Johnson & Johnson vs TotalEnergies SE
A closer look at the financial trajectory of Johnson & Johnson and TotalEnergies SE rounds out the comparison.
Johnson & Johnson: Johnson & Johnson's FY2025 sales increased 6.0% to $94.193 billion. Net earnings rose to $26.804 billion, helped by operating performance and other income items. Innovative Medicine generated $60.401 billion in sales, while MedTech generated $33.792 billion.
TotalEnergies SE: TotalEnergies reported $182.344 billion in 2025 revenues from sales, down from $195.610 billion in 2024 as hydrocarbon prices declined. Net income attributable to TotalEnergies was $13.127 billion, while adjusted net income was $15.587 billion and adjusted EBITDA was $40.555 billion.
Company-Specific SWOT Notes
Johnson & Johnson
Johnson & Johnson's advantage comes from scale, R&D depth, global regulatory capability, major oncology and immunology franchises, MedTech breadth, and a large commercial infrastructure.
Johnson & Johnson wins through medical trust, R&D scale, global reach, leading drug franchises, MedTech breadth, and commercial execution.
The biggest risk is patent, pricing, litigation, or R&D pressure that weakens growth in key pharmaceutical and MedTech franchises.
The company is investing in oncology, immunology, neuroscience, cardiovascular MedTech, electrophysiology, surgery, R&D, acquisitions, and global commercial execution.
TotalEnergies SE
TotalEnergies controls over 4,000 service stations and the majority of the premium lubricants market across 40 African countries, providing a stable, high-margin, recession-proof baseline of free cash flow that is completely decoupled from European refining ma
The company is the second-largest global player in liquefied natural gas, controlling a portfolio of long-term upstream production contracts in Qatar, Australia, and the US, combined with a massive midstream shipping fleet and downstream terminals.
The company faces intense regulatory hostility in its home markets of France and Belgium, where the aggressive expansion of the EU Emissions Trading System and the implementation of windfall profit taxes directly confiscate the cash flows generated by its inte
While the African downstream network is highly profitable, it exposes the company to significant geopolitical, security, and foreign exchange risks, as operations in the Sahel region and sub-Saharan Africa are increasingly threatened by political instability a
TotalEnergies is deploying over $5 billion annually to develop utility-scale solar and offshore wind projects, with a target to reach 100 gigawatts of renewable capacity by 2030.
ExxonMobil and Chevron have executed a strategic retreat from the European retail and renewable power markets to focus exclusively on high-return, low-cost unconventional oil production in the Permian Basin and the deepwater Gulf of Mexico.
Head-to-Head Scorecard
| Category | Winner | Why |
|---|---|---|
| Revenue Scale | TotalEnergies SE | TotalEnergies SE reports the larger revenue base ($182.3B), which serves as a core operational scale signal. |
| Profitability Potential | Comparable | Both organizations prioritize market penetration or are at equivalent reporting tiers. |
| Company Age | Johnson & Johnson | Founded in 1886 vs 1924. The earlier pioneer typically commands longer historical institutional legacy. |
| Innovation Moat | Johnson & Johnson | Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity. |
| Scale (Employees) | Johnson & Johnson | A significantly larger reported workforce supports enhanced global distribution capability. |
| Market Cap | Johnson & Johnson | Higher public valuation denotes greater forward-looking investor conviction in earnings potential. |
| Future Outlook | Tied | Strategic auditing assesses that both maintain defensive leadership vectors within their core market clusters. |
Who Wins Each Category?
TotalEnergies SE reports the larger revenue base ($182.3B), which serves as a core operational scale signal.
Both organizations prioritize market penetration or are at equivalent reporting tiers.
Founded in 1886 vs 1924. The earlier pioneer typically commands longer historical institutional legacy.
Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity.
A significantly larger reported workforce supports enhanced global distribution capability.
Who Wins: Johnson & Johnson or TotalEnergies SE?
Reviewed by Swet Parvadiya, May 2026 - Author Profile
Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.
Frequently Asked Questions: Johnson & Johnson vs TotalEnergies SE
Is Johnson & Johnson better than TotalEnergies SE?
Verdict: Between Johnson & Johnson and TotalEnergies SE, TotalEnergies SE is the stronger overall option based on higher annual revenue. The decision still depends on which factors matter most for your needs, but on the weight of the evidence above, TotalEnergies SE comes out ahead in this Johnson & Johnson vs TotalEnergies SE comparison.
Who earns more — Johnson & Johnson or TotalEnergies SE?
TotalEnergies SE earns more with $182.3B in annual revenue versus Johnson & Johnson's $94.2B. TotalEnergies SE leads on total revenue based on latest verified figures.
Which company has higher revenue — Johnson & Johnson or TotalEnergies SE?
Johnson & Johnson reported $94.2B, while TotalEnergies SE reported $182.3B. The revenue leader is TotalEnergies SE based on latest verified figures.
Johnson & Johnson revenue vs TotalEnergies SE revenue — which is higher?
Johnson & Johnson revenue: $94.2B. TotalEnergies SE revenue: $94.2B. TotalEnergies SE has the larger revenue base of the two companies.
Sources & References
- SEC EDGAR: Johnson & Johnson Annual Filings (10-K, 8-K)
- Johnson & Johnson Corporate Website
- Johnson & Johnson Annual Report 2025 - Revenue and Financial Data
- sec.gov
- TotalEnergies SE Corporate Website
- TotalEnergies SE Annual Report 2025 - Revenue and Financial Data
- totalenergies.com
- sec.gov
- totalenergies.com